United States Animal Healthcare Market Insights Forecasts to 2033

• The United States Animal Healthcare Market Size was valued at USD 5.62 Billion in 2023.
• The Market Size is Growing at a CAGR of 10.24% from 2023 to 2033
• The United States Animal Healthcare Market Size is expected to reach USD 14.90 Billion by 2033

The United States Animal Healthcare Market is anticipated to exceed USD 14.90 Billion by 2033, growing at a CAGR of 10.24% from 2023 to 2033.

Market Overview

The animal healthcare market in the United States encompasses a range of products and services designed to enhance the health of animals, including pets and livestock. A few instances of these items and services are veterinary medications, vaccinations, tests, medical devices, and dietary supplements. The market is being driven by the growing demand for animal health products and the increasing recognition of the significance of animal health among livestock producers and pet owners. The animal healthcare market includes the provision of healthcare, medicines, and medical services for the treatment and welfare of animals. This includes livestock (cattle, poultry, pigs, etc.) and other animals used in research or production, as well as companion animals such as dogs, cats, and birds. This industry offers a wide range of goods and services such as vaccinations, surgical instruments, diagnostic tests, veterinary drugs, and feed additives aimed at keeping animals healthy, preventing disease, and increasing production. The US is seeing a sharp increase in the number of pet owners, which is driving up demand for goods and services related to animal healthcare. The American Pet Products Association estimates that 67% of US homes, or around 85 Billion families, are pet owners.

Report Coverage

This research report categorizes the market for the United States animal healthcare market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the animal healthcare market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the animal healthcare market.

Driving Factors

The value of animal health is becoming more widely recognized, and pet owners are spending more money on preventive care for their animals. The demand for goods and services related to animal healthcare has increased as a result. Recent technical developments have brought about several innovations in the animal healthcare sector, including new goods and services. For example, wearable technology, remote monitoring systems, and telemedicine are examples of digital healthcare solutions that are becoming more and more popular with pet owners. One of the world's major producers of cattle is the United States. The livestock industry is expanding due to the growing demand for meat and dairy products, which is also driving up the cost of goods and services related to animal healthcare.

Restraining Factors

Pet owners and livestock producers' access to healthcare services is being hampered by rising costs for veterinary care, medications, and diagnostic tests, particularly in low-income areas. Due to the unequal distribution of veterinary specialists and healthcare facilities, particularly in rural and remote areas, veterinarian services and supplies for animal healthcare are not readily available.

Market Segmentation

The United States animal healthcare market share is classified into type and end-users.

• The dog segment is expected to hold the largest market share through the forecast period.   

The United States animal healthcare market is segmented by animal type into dog, cat, equine, and others. Among them, the dog segment is expected to hold the largest market share through the forecast period. Due to more and more dogs are being adopted. Owners of dogs are reported to have several health benefits from them, such as lowered blood pressure, reduced stress, and depression relief. Furthermore, according to the Veterinary Cancer Society, cancer is the primary cause of death for 48% of dogs, particularly those under the age of ten. Dogs are more vulnerable to many forms of cancer than other companion animals like cats.

• The pharmaceuticals segment dominates the market with the largest market share over the predicted period.

The United States animal healthcare market is segmented by product into vaccines, pharmaceuticals, OTC, prescription, feed additives, diagnostics, and others. Among them, the pharmaceuticals segment dominates the market with the largest market share over the predicted period. The growing use of medications to treat zoonotic and foodborne illnesses that are becoming more common and endangering the health of animals is driving this market.

• The hospital segment dominates the market with the largest market share over the predicted period.

The United States animal healthcare market is segmented by distribution channel into retail, e-commerce, hospital, and pharmacy. Among them, the hospital segment dominates the market with the largest market share over the predicted period. Because of their great accessibility and cost, and they are anticipated to expand gradually. This growth is mostly due to the rising rates of chronic illnesses and epidemics in companion animals as well as the sophisticated medical equipment that hospitals can provide. Because of its better accessibility, ease of use, and time efficiency, e-commerce is expected to grow at the quickest rate.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States animal healthcare market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Elanco
• Zoetis
• Vetoquinol
• Merck & Co. Inc.
• Boehringer Ingelheim Gmbh
• Heska
• Dechra Pharmaceuticals Plc
• Norbrook Inc.
• Idexx Laboratories Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2022, LexaGeneHoldings announced improvements to its sample preparation cartridge for handling complex samples, as well as the development of a fully automated quick pathogen testing instrument called the LexaGenes MiQLab System. This device is intended to handle liquid samples from companion animals that are utilized in the diagnosis of illnesses like skin infections and urinary tract infections (UTIs).

Market Segment

This study forecasts revenue at United States, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the United States Animal Healthcare Market based on the below-mentioned segments:

United States Animal Healthcare Market, By Animal Type

• Dog
• Cat
• Equine
• Others

United States Animal Healthcare Market, By Product

• Vaccines
• Pharmaceuticals
• OTC
• Prescription
• Feed Additives
• Diagnostics
• Others

United States Animal Healthcare Market, By Distribution Channel

• Retail
• E-commerce
• Hospital
• Pharmacy